CTEP

Uses your system voice; voice and rate in settings.

Q5014559Snapshot

≈ 1 min read

Names in other languages

  • EnglishCTEP
  • shCTEP
  • СрпскиCTEP

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

CTEP (Ro4956371) is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR 5 , binding with nanomolar affinity and over 1000 times selectivity over all other receptor targets tested. In animal studies it was found to have a high oral bioavailability and a long duration of action, lasting 18 hours after a single dose, giving it considerably improved properties over older mGluR 5 antagonists such as MPEP, MTEP and fenobam.

CTEP (Ro4956371) is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR 5 , binding with nanomolar affinity and over 1000 times selectivity over all other receptor targets tested. In animal studies it was found to have a high oral bioavailability and a long duration of action, lasting 18 hours after a single dose, giving it considerably improved properties over older mGluR 5 antagonists such as MPEP, MTEP and fenobam.

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1376983489 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.